Images List Premium Download Classic

Infectious

Infectious-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Proximity tracing methods and systems
July 20, 2017 - N°20170206334

Infection control methods and systems associate proximity-detection devices with people in a population, such as people in a hospital. Each proximity-detection device detects proximity events with other people. The methods and systems detect proximity events and, for person-to-person pairs who were involved in such an event, records at least one risk value as a measure of risk of an infectious ...
Automated immunoanalyzer system for performing diagnostic assays for autoimmune and infectious diseases
Hycor Biomedical, Llc
July 20, 2017 - N°20170205410

A quantitative method for diagnosing an autoimmune disease or an infectious disease comprising performing an automated diagnostic assay, comprising: incubating a capture reagent with a streptavidin-coated medium to form a solid phase complex, wherein the capture reagent is a biotinylated autoantigen or infectious disease antigen; washing the solid phase complex to remove excess capture reagent; incubating the solid phase complex ...
Il-33 antagonists and uses thereof
Hycor Biomedical, Llc
July 20, 2017 - N°20170204158

The present invention provides interleukin-33 (il-33) antagonists comprising one or more il-33-binding domains and one or more multimerizing domains and methods of using the same. According to certain embodiments of the invention, the il-33-binding domains can comprise an il-33-binding portion of an st2 protein and/or an extracellular portion of an il-1racp protein. The il-33 antagonists ...
Infectious Patent Pack
Download 268+ patent application PDFs
Infectious Patent Applications
Download 268+ Infectious-related PDFs
For professional research & prior art discovery
inventor
  • 268+ full patent PDF documents of Infectious-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group
Bayer Pharma Aktiengesellschaft
July 20, 2017 - N°20170202815

The present invention relates to 5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group of general formula (i) as described and defined herein, and methods for their preparation, their use for the treatment and/or prophylaxis of disorders, in particular of hyper-proliferative disorders and/or virally induced infectious diseases and/or of cardiovascular diseases. The invention further relates to ...
Agents for the treatment of retroviral infectious diseases
Immunologik Gmbh
July 20, 2017 - N°20170202814

The invention relates to pyridine-3,5-bis-thiocyanates which are new active substances for the treatment and prevention of retroviral infections and secondary diseases thereof, in particular hiv infections and aids, from the group of deubiquitinase inhibitors. Administration of the compounds of the invention increases the immunogenicity of viral proteins and thus the antiviral response.
Cultivation method of coffee tree by red ginseng powdered extract
Immunologik Gmbh
July 20, 2017 - N°20170202235

A cultivation method of coffee tree by red ginseng powdered extract is provided, and particularly provided is a cultivation method of coffee tree through environment-friendly and rest (artificial dormant period) process using a red ginseng, and drink composition and food additive manufactured by the cultivation method of coffee tree by red ginseng, the method including: supplying red ginseng powdered extract ...
Infectious Patent Pack
Download 268+ patent application PDFs
Infectious Patent Applications
Download 268+ Infectious-related PDFs
For professional research & prior art discovery
inventor
  • 268+ full patent PDF documents of Infectious-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Anti-tigit antibodies
Merck Sharp & Dohme Corp.
July 13, 2017 - N°20170198042

The present invention relates to anti-tigit antibodies, as well as use of these antibodies in the treatment of diseases such as cancer and infectious disease.
Antibody molecules to tim-3 and uses thereof
Children's Medical Center Corporation
July 13, 2017 - N°20170198041

Antibody molecules that specifically bind to tim-3 are disclosed. The anti-tim-3 antibody molecules can be used to treat, prevent and/or diagnose immune, cancerous, or infectious conditions and/or disorders.
Multispecific nkp46 binding proteins
Innate Pharma
July 13, 2017 - N°20170198038

Multispecific proteins that bind and specifically redirect nk cells to lyse a target cell of interest are provided without non-specific activation of nk cells in absence of target cells. The proteins have utility in the treatment of disease, notably cancer or infectious disease.
Single chain antigen recognizing constructs (scarcs) stabilized by the introduction of novel disulfide bonds
Universitätsmedizin Der Johannes Gutenberg-universität Mainz
July 13, 2017 - N°20170198029

The present invention relates to a single chain antigen recognizing construct (scarc), which is composed of stabilized variable domains by the introduction of novel disulfide bonds, in order to prevent residual mis-pairing with endogenous arc chains. The invention further discloses a method for the design of a novel structurally stabilized scarc, the method being based on the visual inspection of ...
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or ...
Curevac Ag
July 13, 2017 - N°20170196967

The present invention relates to a nucleic acid sequence, comprising or coding for a coding region, encoding at least one peptide or protein comprising a pathogenic antigen or a fragment, variant or derivative thereof, at least one histone stem-loop and a poly(a) sequence or a polyadenylation signal. Furthermore the present invention provides the use of the nucleic acid for ...
Drug target and construct for japanese encephalitis virus infection
Curevac Ag
July 13, 2017 - N°20170196963

A group of mosquito-borne flaviviruses that cause fatal encephalitis in humans is among the most important of all emerging human pathogens of global significance. This group includes japanese encephalitis virus (jev), west nile virus, st. Louis encephalitis virus, and murray valley encephalitis virus. In the present disclosure, the first reverse genetics system has been developed for sa14-14-2, a ...
Prime-boost regimens with a tlr4 agonist adjuvant and a lentiviral vector
Immune Design Corp.
July 13, 2017 - N°20170196954

Compositions and methods are provided herein for improved dual immunization strategies that induce in a subject a robust immune response. The methods described are therefore useful for treating and/or preventing (i. E., reducing the likelihood or risk of occurrence) different diseases, disorders, and conditions such as cancers and infectious diseases for which induction of a humoral immune response and/...
Infectious Patent Pack
Download 268+ patent application PDFs
Infectious Patent Applications
Download 268+ Infectious-related PDFs
For professional research & prior art discovery
inventor
  • 268+ full patent PDF documents of Infectious-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Perforin 2 defense against invasive and multidrug resistant pathogens
University Of Miami
July 06, 2017 - N°20170191058

Perforin-2 (p2) is expressed by fibroblasts, microglia and macrophages and was found to be responsible for killing bacteria, for example, mycobacteria smegmatis, m. Avium, salmonellae, mrsa (drug resistant stapholococci), e. Coli. Compounds identified by screening assays are selected based on the effects of these compounds on p2. Use of these compounds in the treatment of infectious diseases, in particular, bacteria ...
Antibody molecules to tim-3 and uses thereof
Children's Medical Center Corporation
July 06, 2017 - N°20170190777

Antibody molecules that specifically bind to tim-3 are disclosed. The anti-tim-3 antibody molecules can be used to treat, prevent and/or diagnose immune, cancerous, or infectious conditions and/or disorders.
Vacuum assisted percutaneous applicance
Viaderm, Llc
July 06, 2017 - N°20170189663

A luminal access device is provided that includes a luminal graft attached to a patient lumen. A percutaneous access device (pad) is coupled to the luminal graft and adapted to stabilize a conduit in fluid communication with the luminal graft and an external medical device. A portion of said pad adapted to be external to the patient and seal around ...
New medical agents and uses thereof
Lokon Pharma Ab
July 06, 2017 - N°20170189480

The invention provides a novel compounds derived from cd154, but without the intracellular domain. Notably, the invention provides tmz-cd154 and a method to treat diseases in which the novel molecule tmz-cd154 is used. In particular, tmz-cd154 is used to modify the immune responses in patients with immune related diseases such as cancer and infectious disease. The invention also relates to ...
Composition for preventing or treating staphylococcus aureus infection
Pusan National University Industry-university Cooperation Foundation
July 06, 2017 - N°20170189473

A composition containing wall teichoic acid-attached peptidoglycan (wta-pgn) as an active ingredient, a method for preventing or treating staphylococcus aureus infectious diseases using the composition, and a method for preparing a soluble wta-pgn which can be used as an active ingredient in the composition are provided. The composition of the present invention can be effectively used for preventing or treating ...
Novel bacteriophage and composition comprising same
Cj Cheiljedang Corporation
July 06, 2017 - N°20170189460

The present invention relates to a novel bacteriophage Φcj26 (kccm11464p) and a composition comprising the same as an active ingredient. In addition, the present invention relates to a method for preventing and/or treating infectious diseases caused by salmonella by using the bacteriophage Φcj26 (kccm11464p) or the composition.
Novel bacteriophage and composition comprising same
Cj Cheiljedang Corporation
July 06, 2017 - N°20170189459

The present invention relates to a novel bacteriophage Φcj24 (kccm11462p) and a composition comprising the same as an active component. In addition, the present invention relates to a method for preventing and/or treating infectious diseases caused by avian pathogenic e. Coli of birds by using the bacteriophage Φcj24 (kccm11462p) or the composition.
Amide compounds, methods for preparation, and use thereof as agents for the treatment and prevention ...
Obschestvo S Ogranichennoi Otvetstvennostiyu "pharmenterprises"
June 29, 2017 - N°20170183318

The present invention relates to medicine and includes a method for preventing and treating diseases caused by rna- and dna-containing viruses, and concomitant diseases, wherein the method comprises the use of an effective amount of compounds of general formula i or pharmaceutically acceptable salts thereof. The invention also relates to methods for preparing said compounds, pharmaceutical compositions for the prevention ...
Loading